Asthma is a diverse disease that affects over 300 million individuals globally. The prevalence of asthma has increased by 50% every decade since the 1960s, making it a serious global health issue. In addition to its associated high mortality, asthma generates large economic losses due to the degradation of patients’ quality of life and the impairment of their physical fitness. Asthma research has evolved in recent years to fully analyze why certain diseases develop based on a variety of data and observations of patients’ performance. The advent of new techniques offers good opportunities and application prospects for the development of asthma diagnosis methods. Over the last few decades, techniques like data mining and machine learning have been utilized to diagnose asthma. Nevertheless, these traditional methods are unable to address all of the difficulties associated with improving a small dataset to increase its quantity, quality, and feature space complexity at the same time. In this study, we propose a sustainable approach to asthma diagnosis using advanced machine learning techniques. To be more specific, we use feature selection to find the most important features, data augmentation to improve the dataset’s resilience, and the extreme gradient boosting algorithm for classification. Data augmentation in the proposed method involves generating synthetic samples to increase the size of the training dataset, which is then utilized to enhance the training data initially. This could lessen the phenomenon of imbalanced data related to asthma. Then, to improve diagnosis accuracy and prioritize significant features, the extreme gradient boosting technique is used. The outcomes indicate that the proposed approach performs better in terms of diagnostic accuracy than current techniques. Furthermore, five essential features are extracted to help physicians diagnose asthma.

Background: Ovarian cancer is a difficult and lethal illness that requires early detection and precise classification for effective therapy. Microarray technology has permitted the simultaneous assessment of hundreds of genes’ expression levels, yielding important insights into the molecular pathways driving ovarian cancer. To reduce computational complexity and improve accuracy, choosing the most likely differential genes to explain the impacts of ovarian cancer is necessary. Medical datasets, including those related to ovarian cancer, are often limited in size due to privacy concerns, data collection challenges, and the rarity of certain conditions. Data augmentation allows researchers to expand the dataset, providing a larger and more diverse set of examples for model training. Recent advances in machine learning and bioinformatics have shown promise in improving ovarian cancer classification based on gene information. Methods: In this paper, we present an ensemble algorithm based on gene selection, data augmentation, and boosting approaches for ovarian cancer classification. In the proposed approach, the initial genetic data were first subjected to feature selection. Results: The target genes were screened and combined with data augmentation and ensemble boosting algorithms. From the results, the chosen ten genes could accurately classify ovarian cancer at 98.21%. Conclusions: We further show that the proposed algorithm based on clustering approaches is effective for real-world ovarian cancer data, with 100% accuracy and strong performance in distinguishing between distinct ovarian cancer subtypes. The proposed algorithm may help doctors identify ovarian cancer patients early and develop individualized treatment plans.

Ovarian cancer stands out as one of the most formidable adversaries in women’s health, largely due to its typically subtle and nonspecific early symptoms, which pose significant challenges to early detection and diagnosis. Although existing diagnostic methods, such as biomarker testing and imaging, can help with early diagnosis to some extent, these methods still have limitations in sensitivity and accuracy, often leading to misdiagnosis or missed diagnosis. Ovarian cancer’s high heterogeneity and complexity increase diagnostic challenges, especially in disease progression prediction and patient classification. Machine learning (ML) has outperformed traditional methods in cancer detection by processing large datasets to identify patterns missed by conventional techniques. However, existing AI models still struggle with accuracy in handling imbalanced and high-dimensional data, and their “black-box” nature limits clinical interpretability. To address these issues, this study proposes SHAP-GAN, an innovative diagnostic model for ovarian cancer that integrates Shapley Additive exPlanations (SHAP) with Generative Adversarial Networks (GANs). The SHAP module quantifies each biomarker’s contribution to the diagnosis, while the GAN component optimizes medical data generation. This approach tackles three key challenges in medical diagnosis: data scarcity, model interpretability, and diagnostic accuracy. Results show that SHAP-GAN outperforms traditional methods in sensitivity, accuracy, and interpretability, particularly with high-dimensional and imbalanced ovarian cancer datasets. The top three influential features identified are PRR11, CIAO1, and SMPD3, which exhibit wide SHAP value distributions, highlighting their significant impact on model predictions. The SHAP-GAN network has demonstrated an impressive accuracy rate of 99.34% on the ovarian cancer dataset, significantly outperforming baseline algorithms, including Support Vector Machines (SVM), Logistic Regression (LR), and XGBoost. Specifically, SVM achieved an accuracy of 72.78%, LR achieved 86.09%, and XGBoost achieved 96.69%. These results highlight the superior performance of SHAP-GAN in handling high-dimensional and imbalanced datasets. Furthermore, SHAP-GAN significantly alleviates the challenges associated with intricate genetic data analysis, empowering medical professionals to tailor personalized treatment strategies for individual patients.